Minimally invasive robot-B (02252) rose more than 5%. As of press release, it was up 4.81% to HK$19.6, with a turnover of HK$7.164,900.
The Zhitong Finance app learned that Minimally Invasive Robot-B (02252) rose more than 5%. As of press release, it had risen 4.81% to HK$19.6, with a turnover of HK$7.164,900.
According to the news, recently, the minimally invasive robot Zumai four-arm endoscopic surgery robot (hereafter: Tumai robot) won the bid several times. Up to now, Tumai Robotics has won bids in more than 15 hospitals in various provinces across the country, ranking first in sales of domestic brand endoscopic surgery robots. Among them, 6 of the top 100 hospitals in the country (Fudan edition) won the bid, accounting for about 40%.
Societe Generale Securities said that early installation is a critical stage for verifying product strength and building reputation. With the release of clinical demand, the resumption of procurement activities, the broadening of indications, and the increase in product strength, endoscopic robots are expected to experience a further increase in installed capacity in 2024, driving rapid revenue growth for related enterprises.